The adrenal hormones may, on the one hand, activate at least mutated AR, a frequent mechanism in PCa to provoke resistance to hormonal therapy [21], but on the other hand, also elevate fasting glucose levels in PCa patients by introducing insulin resistance. This evidence concerns the gene AR and posterior cortical atrophy.